Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation. Li W, Wang R, Wang J, Chai D, et al. Blood 2025;145:1047-1060.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li W, Wang R, Wang J, Chai D, et al. Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation. Blood 2025;145:1047-1060.
PMID: 39576960